Answers are grounded in this paper and cite their sources.
Case report reveals a novel CRYAB variant causing early-onset cardiomyopathy and arrhythmias in a young patient, suggesting genetic testing's value.
Background Dilated cardiomyopathy (DCM) is a major cause of heart failure in young patients, with a genetic aetiology identified in up to 40% of cases. Variants in *CRYAB*, encoding the small heat shock protein αB-crystallin, are rare but increasingly recognised in inherited cardiomyopathies. Case summary We report a 16-year-old male who presented with progressive heart failure symptoms and palpitations. Transthoracic echocardiography revealed a dilated left ventricle with severely reduced systolic function. Holter monitoring documented episodes of ventricular tachycardia. Cardiac magnetic resonance demonstrated global biventricular systolic dysfunction and focal mid-wall late gadolinium enhancement in the interventricular septum. Genetic testing identified a novel heterozygous *CRYAB* variant (p.Arg69Cys), confirmed by Sanger sequencing, together with a *PSEN2* variant of uncertain significance. The patient was treated with guideline-directed medical therapy for heart failure and underwent prophylactic implantable cardioverter–defibrillator implantation. Clinical status and left ventricular function improved during follow-up. Discussion This case highlights the importance of integrating advanced cardiac imaging and genetic testing in young patients with unexplained DCM and malignant ventricular arrhythmias. Novel *CRYAB* variants may be associated with early-onset DCM and arrhythmic risk, influencing prognostic assessment and management.
No takes yet. Share an insight, caveat, or question.
Vy Le Tran (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: